OptiCept Technologies

Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

OptiCept Technologies Year-End Report Q4 2025

MAR

OptiCept Technologies AB (publ), today published its Year-End Report for Q4 2025 (January – December 2025).

SIGNIFICANT EVENTS Q4 2025

  • Operating profit for the fourth quarter is negatively impacted by non-cash, non-recurring items amounting to 21,7 MSEK.
  • OptiCept refinances loans of approximately SEK 21.4 million and receives additional liquidity through a new loan of approximately SEK 17.5 million, as well as establishing a credit facility of SEK 10 million
  • An extraordinary general meeting partially elected a new board and followed the nomination committee’s proposal
  • OptiCept Technologies AB announces Nomination Committee ahead of the 2026 Annual General Meeting

SIGNIFICANT EVENTS AFTER PERIOD END

  • OptiCept expands its global agreement with FPS, secures license revenues of approximately SEK 150 million in the first 5 years, and achieves positive EBITDA in the second half of 2026
  • OptiCept Technologies AB launches cost-efficiency program
  • Lenders and issuers of credit facilities request early conversion of loans, including arrangement fees and accrued interest, of at least approximately SEK 39.8 million into shares
  • Henrik Nettersand assumes the role of Acting CEO following Thomas Lundqvist’s departure from OptiCept Technologies AB
  • OptiCept receives two breakthrough orders in French fries through FPS Food Process Solutions
  • OptiCept reports positive cutting results from Indonesia
FINANCIAL OVERVIEW    
     
KSEK (unless otherwise stated)*Q4 (oct-dec)Q1-Q4 (jan-dec)
 2025202420252024
Net Sales**9295 38527 23617 674
Total revenue**1 4598 00337 33832 791
Operating Income-48 185-17 503-84 330-56 094
Result for the period-51 306-17 531-90 488-55 699
Inbound Orders***11189827 30212 194
Open orders***7 7927 9947 7927 994
Reported EBITDA-43 717-14 848-72 105-42 538
Net result for the period368 701392 326368 701392 326
Cash & cash equivalents2 61221 6772 61221 677
Equity278 793362 241278 793362 241
Equity ratio (%)76%92%76%92%
Average number of shares in the period63 138 28455 254 16662 912 82748 300 540
Number of shares at the end of the period64 844 68362 769 68364 844 68362 769 683
Earnings per share before and after dilution (SEK)-0,81-0,32-1,44-1,15
Cash flow from operating activities-13 866-15 461-43 574-48 263
Total Cash flow-1 01217 119-19 0657 563
     
For information regarding alternative performance measures, please refer to Note 5.
* Rounding may occur so that in some cases the amounts do not add up
** For information regarding net revenue, please refer to Note 2.
***Open orders excluding FPS, please refer to Note 1    

The report is available on the company's website: https://investor.opticept.se/finansiell-information/finansiella-rapporter/

Datum 2026-03-27, kl 08:00
Källa MFN